Europe transfection reagents and equipment market was valued at USD 105.02 million in 2017 and growing at a lucrative rate of CAGR in the assessment period. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.
Prominent factors driving the growth of this market consist of technology advancements in the transfection technology, rising prevalence of chronic cases, increase in demand of chimeric genes growing alliances between the leading research institutes to trigger drug discovery, increasing R&D spending and research activities by pharmaceutical and biotech companies and rising research activities in cell science.

The key market players for Europe transfection reagents and equipment market are listed below;

Thermo Fisher Scientific Inc.
QIAGEN
Promega Corporation
Bio-Rad Laboratories, Inc.
MAXCYTE, INC.
LONZA
Polyplus-transfection SA
Mirus Bio LLC
Sigma-Aldrich, Inc.
SignaGen Laboratories
Genlantis, Inc

The market is further segmented into;
Product
Method
Application
End users


The Europe transfection reagents and equipment market is segmented based on products into two segments; reagents and equipment. In 2018, reagents segment is estimated to rule with 79.4% shares, rising at a specified CAGR. However, equipment is growing at the highest CAGR in the forecast period of 2018 to 2025.
The Europe transfection reagents and equipment market is segmented based on method categories into three segments; biochemical methods, physical and viral method. In 2018, physical segment is valued to rule with highest market shares, rising at the highest CAGR. Physical segment is dominating the market as it was the initial choice for the transfection and highly efficient. Physical method is further sub segmented into electroporation, nucleofection and others. Other physical method is further divided into genegun, magnetofection, sonoporation and optoinjection. Biochemical method is segmented into lipofection, calcium phosphate, deae-dextran and dendrimers. Viral method is divided into 4 sub segments including adenoviruses, retroviruses, adeno associated viruses and others.
Based on application, the Europe transfection reagents and equipment market is segmented into biomedical research, protein production and therapeutic delivery. In 2018, protein production segment is projected to rule with the highest market shares, rising at the highest CAGR. Protein production is dominating the market as protein is essential requirement for food, healthcare and cosmetics so the protein production is the major application of transfection procedure. Biomedical application is further sub segmented into gene expression studies, cancer research and transgenic models.
The Europe transfection reagents and equipment market is segmented based on end user into two notable segments; academics & research institutes and pharmaceutical & biotechnology companies. In 2018, academics & research institutes segment is likely to rule with highest market shares, rising at the highest CAGR. The academics & research institutes are dominating the market as more research is being carried out in research organizations. And research organizations later on licensed out to industries for further development of products.
Based on geography, the market is segmented into;
Germany
France
U.K.
Spain
Italy
Switzerland
Netherlands
Russia
Turkey
Belgium
Rest of Europe
Covered in this report
The report covers the present scenario and the growth prospects of the Europe transfection reagents and equipment for 2018-2025. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.
You can request one free hour of our analyst?s time when you purchase this market report. Details are provided within the report.